Safety, Adulteration and Product Quality

Most herb-safety pages are about the herb. This one mostly is not, and that is the finding, not an evasion.

Epimedium leaf itself appears to be reasonably well tolerated at ordinary doses over short periods. It carries some real cautions — oestrogenic activity, liver-injury reports, a single cardiac case report — and those are covered in full below. But the dominant risk attached to buying horny goat weed is not pharmacological. It is that the product category it is sold into is systematically adulterated with prescription drugs, in quantities that can exceed the maximum approved dose, with no warning label, sold to people who have never been medically screened.

The numbers below are not estimates or scare copy. They are counts from published analytical surveys and from the U.S. Food and Drug Administration’s own database.

Table of Contents

  1. What the Analytical Surveys Actually Found
  2. One Product, Fifteen Years, Eight Drugs
  3. Why a Hidden PDE5 Inhibitor Can Kill
  4. How to Spot a Suspect Product
  5. The Herb’s Own Risks
  6. Liver Injury
  7. Oestrogenic Activity
  8. Drug Interactions
  9. Who the Research Raises Concerns For
  10. Reading a Label
  11. Key Research Papers
  12. Connections
  13. Featured Videos

What the Analytical Surveys Actually Found

The French academic survey: 150 products, NMR spectroscopy

A group at the Université Paul Sabatier in Toulouse bought 150 dietary supplements marketed for sexual performance, every one of which claimed to contain only natural compounds, plant extracts or vitamins, and analysed them by proton nuclear magnetic resonance (NMR) with mass spectrometry confirmation. The results, published in 2015:

One detail is worth pausing on. A small fraction — 2.5 percent — contained genuine plant-derived compounds including icariin. In a survey of 150 products sold on the strength of botanical claims, the botanical was the rare finding and the pharmaceutical was the common one.

The US convenience-store survey

A separate 2013 study collected 91 samples representing 58 distinct products, almost all bought from convenience stores and filling stations in two American metropolitan areas, priced between $2.99 and $17.99, and analysed them by liquid chromatography–mass spectrometry. No sample claimed to contain any synthetic substance.

The French academic group found the same pattern by a different analytical method on a different continent, and the U.S. Food and Drug Administration’s own regulatory record — below — is a third, independent line of evidence pointing the same way.

The U.S. Food and Drug Administration’s own record

Investigators at the California Department of Public Health analysed the U.S. Food and Drug Administration’s Tainted Products Marketed as Dietary Supplements database for 2007 through 2016 and published the summary in JAMA Network Open:

One Product, Fifteen Years, Eight Drugs

The Toulouse group later published a case history that captures the whole problem in one product line. They analysed ten samples of a supplement sold as a 100 percent natural aphrodisiac, purchased between 2007 and 2022.

The authors’ conclusion was blunt: this demonstrates the impossibility of controlling this market. They called for a European public database of tainted supplements modelled on the U.S. Food and Drug Administration’s, with product names, photographs and named adulterants.

Why a Hidden PDE5 Inhibitor Can Kill

Sildenafil is a good drug. Prescribed properly, it is safe, cheap as a generic, and has been used by tens of millions of men. The danger is not the molecule. It is receiving the molecule without knowing it, at an unknown dose, without any of the screening that precedes a prescription.

The nitrate interaction

This is the one that kills people. Nitrate medicines — nitroglycerin spray or tablets, isosorbide mononitrate, isosorbide dinitrate — work by donating nitric oxide, which drives production of cyclic guanosine monophosphate (cGMP) and relaxes blood vessels. A PDE5 inhibitor blocks the enzyme that destroys cGMP. Give both and cGMP accumulates without a brake: vessels throughout the body dilate at once, blood pressure collapses, and the fall can be profound, prolonged and resistant to treatment. The consequences include myocardial infarction, stroke and death. The contraindication on every PDE5 inhibitor label is absolute, not relative.

Now consider who takes nitrates: people with angina — that is, people with coronary artery disease. And consider who has erectile dysfunction: disproportionately, people with coronary artery disease, because both are manifestations of the same endothelial pathology. The overlap between the group at risk from this interaction and the group buying these products is not small. It is the same population.

Recreational nitrites — amyl, butyl or isopropyl nitrite, sold as “poppers” carry the identical interaction, and the overlap with sexual-enhancement supplements is obvious.

The other hazards of an unscreened dose

How to Spot a Suspect Product

You cannot detect adulteration by taste, appearance or price. But the pattern of a spiked product is recognisable, and these signals track closely with what the analytical surveys found.

SignalWhy it matters
Sold at a filling station, convenience store, adult shop or vending machineThe exact sampling frame in which 81 percent of products tested drug-positive
Single-serve sachet or blister of one or two capsulesA drug-dose format, not a supplement format. Nobody sells a two-day supply of a herb
Promises results in 30–60 minutes, or effects lasting daysDescribes PDE5 pharmacokinetics. A leaf extract cannot do this
Aggressive brand name evoking hardness, power, rhinos, tigers or numbers of hoursConsistently over-represented in U.S. Food and Drug Administration warning lists
“Proprietary blend” with no per-ingredient milligramsLegally shields the formula from disclosure, which is the point
No lot number or expiry date; inconsistent packagingDocumented in the adulteration surveys as a marker of no quality system
No warning about nitrates anywhere on the labelOnly 14 of 91 tested samples carried one — and 74 of them contained a PDE5 drug
Bought from an overseas web shop or arriving by international mailIn 2014–2016, 117 of 303 adulterated samples the U.S. Food and Drug Administration identified (38.6 percent) came from online sampling and 104 of 303 (34.3 percent) from examining international mail shipments
Sold with the claim that it is “like sildenafil but natural”Half of that sentence is often literally true

The U.S. Food and Drug Administration’s Tainted Sexual Enhancement Products database is free and searchable by brand name, and it lists the product, the company and the hidden drug found.

The Herb’s Own Risks

Set the adulteration problem aside and consider genuine Epimedium leaf.

The reassuring data point is the 2021 Singapore trial: 58 postmenopausal women took 740 mg per day of a purified prenylflavonoid extract for six weeks under double-blind conditions, with no significant adverse symptoms and no changes in liver, kidney or blood parameters. That is a real, monitored human safety signal and it is worth having. It is also six weeks in 29 treated women, which is a long way from establishing safety for indefinite daily use.

The same trial measured what actually reached the blood. After the extract, the main forms circulating were desmethylicaritin, icaritin and icariside II; icariin itself, and icariside I, stayed below detection levels. That matters for the liver section below, because icaritin is the metabolite the liver-injury research points to.

Cardiac effects

There is one published case report: a man who developed a tachyarrhythmia together with hypomania while taking horny goat weed, reported in Psychosomatics in 2004. A single case report proves nothing about causation — the report itself does not claim to. But it is not nothing either, given that this is a plant with documented vascular activity, and it is the reason the research raises a concern for anyone with a known arrhythmia or structural heart disease.

Commonly reported side effects

At higher intakes, users report dizziness, dry mouth, thirst, nosebleeds, nausea and a racing heartbeat. These are not well quantified because no adequately powered long-term trial has collected them systematically.

Liver Injury

This deserves its own section because it is the herb’s most substantiated intrinsic risk and it is not widely known in the West.

A 2024 study in Biomedical Chromatography from Beijing University of Chinese Medicine opens with this statement: Epimedium has been the subject of numerous adverse-reaction reports in recent years, and the most common of these is liver injury. The researchers profiled the herb’s constituents, identified those absorbed into blood, and used network analysis plus metabolomics in human liver cells to nominate a likely culprit — icaritin, one of the sugar-stripped metabolites that human pharmacokinetic work shows actually circulates after an oral dose. A 2024 systematic review of Epimedium koreanum similarly gives toxicity its own treatment rather than a footnote.

Hospital records point the same way. Peking University First Hospital in Beijing reviewed the records of 726 people treated for drug-induced liver injury between January 1995 and August 2019. Chinese herbal medicines caused 353 of the cases (48.6 percent), and Epimedium was the third most common herbal cause, with 26 cases, after Polygonum multiflorum (38 cases) and Fructus Psoraleae (35 cases). The herbal cases had higher liver-enzyme and bilirubin levels, and more of them were severe, than the cases caused by Western drugs.

Two things follow. Herb-induced liver injury is usually idiosyncratic: unpredictable, not dose-related in any simple way, and not preventable by taking a smaller amount. And the mechanism proposed here implicates a metabolite that is more abundant after processing or prolonged use, not less.

Signs of liver injury that hospitals treat as urgent: yellowing of the skin or the whites of the eyes, dark urine, pale stools, persistent nausea, unusual fatigue, itching without a rash, or pain under the right ribs. The research raises the greatest concern for anyone with existing liver disease, or taking other hepatotoxic (liver-harming) drugs.

Oestrogenic Activity

In rat bone-like cells (UMR-106 cells), some Epimedium flavonoids switched on oestrogen-receptor-alpha signalling without binding the receptor: none of the four flavonoids tested bound oestrogen receptor alpha or beta, and only two of them appeared to act through receptor alpha. This oestrogen-like action is the leading explanation for the herb’s effect on bone density. The same property raises a concern elsewhere.

The 2007 bone trial provides real reassurance for healthy women: over 24 months, neither serum oestradiol nor endometrial thickness changed in either group. That is a meaningful negative safety finding in exactly the tissue people worry about. But the trial enrolled healthy postmenopausal women with no hormone-sensitive disease. It cannot be extrapolated to someone with an oestrogen-driven tumour, and no study has tried.

Without better data, the research raises a concern for anyone who has or has had oestrogen-receptor-positive breast cancer, endometrial cancer, ovarian cancer, endometriosis, or uterine fibroids. For people taking tamoxifen or an aromatase inhibitor, the theoretical interference from a phyto-oestrogen has never been studied.

Drug Interactions

Drug or classConcernWhat is known
Nitrates — nitroglycerin, isosorbide mono/dinitrate; recreational nitritesCatastrophic hypotension if the product contains a PDE5 inhibitor, declared or notAn absolute contraindication on every PDE5 inhibitor label
PDE5 inhibitors — sildenafil, tadalafil, vardenafil, avanafilAdditive effect; unknown total dose if the supplement is spikedThe combined dose cannot be known
Alpha-blockers — tamsulosin, doxazosin, alfuzosinSymptomatic hypotension, dizziness, fallsPrescribers separate the doses and start low; a supplement does neither
Antihypertensives generallyAdditive blood-pressure lowering; the herb has vascular activity and spiked products far more soBlood-pressure readings show the combined effect
Anticoagulants and antiplatelets — warfarin, apixaban, rivaroxaban, clopidogrel, aspirinInteraction data are sparse rather than reassuring. Bleeding risk cannot be excludedThe combination has not been properly studied
Antiarrhythmics, or any known arrhythmiaCase report of tachyarrhythmiaOne published case report (2004)
Hepatotoxic drugs — methotrexate, isoniazid, high-dose paracetamol, some statinsAdditive liver riskLiver-enzyme blood tests detect liver injury
Oestrogens, tamoxifen, aromatase inhibitorsOestrogen-receptor-alpha activation may interfereThe theoretical interference has never been studied
Drugs cleared by glucuronidationA test-tube study reported that icariin inhibits UDP-glucuronosyltransferases (Ugt1 family); in mice given icariin by mouth for 7 days, liver UDP-glucuronosyltransferase activity was basically unaltered and the Ugt1 genes were not suppressedNo interaction has been demonstrated in people
SurgeryBlood-pressure and bleeding uncertaintyHerbal supplements are commonly stopped two weeks before surgery, and anaesthetists ask about them

Who the Research Raises Concerns For

Reading a Label

For genuine Epimedium, the label is the only information a buyer has.

Label itemComplete labelIncomplete or suspect
Latin binomialEpimedium brevicornu, E. sagittatum, E. koreanum or E. pubescens“Horny goat weed” with no species
Plant partLeaf / aerial parts (Epimedii Folium)Unspecified, or “whole plant”
MarkerIcariin, given as a percentage and mg per capsule“Standardised” with no marker named
FormulaSingle herb, or every ingredient with its own mgAny “proprietary blend”
TestingNamed third-party laboratory; certificate of analysis on request; ideally explicit screening for PDE5-inhibitor adulterantsA Good Manufacturing Practice (GMP) logo alone
TraceabilityManufacturer address, lot number, expiry dateAny of these missing
ClaimsRestrained, specific, no timing promisesAnything implying drug-like speed or reliability
RetailerEstablished pharmacy or supplement retailer with a returns policyPetrol station, adult shop, marketplace listing, unbranded overseas seller

The warning signs that matter most are chest pain, palpitations, fainting, unusual bruising or bleeding, jaundice and dark urine — and an erection lasting more than four hours (priapism), a urological emergency that hospitals treat as urgent.

Back to Table of Contents

Key Research Papers

Each identifier below was verified live against NCBI E-utilities — first author, title, journal and year all had to match. All figures quoted in this article come from the abstracts of these papers.

Adulteration surveys

  1. Gilard V, Balayssac S, Tinaugus A, Martins N, Martino R, Malet-Martino M. Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance. Journal of Pharmaceutical and Biomedical Analysis. 2015;102:476–493 — PubMed PMID: 25459948 — 61 percent adulterated with PDE5 inhibitors; only 31 percent genuinely natural.
  2. Balayssac S, Danoun S, Gilard V, Martino R, Malet-Martino M. The [product] saga from 2007 to 2022: an example of a sexual enhancement dietary supplement tainted by different adulterants and still on the market. Journal of Pharmaceutical and Biomedical Analysis. 2023;227:115283 — PubMed PMID: 36780864 — Ten samples over fifteen years, eight adulterants, 15–145 mg per capsule.
  3. Campbell N, Clark JP, Stecher VJ, Thomas JW, Callanan AC, Donnelly BF, Goldstein I, Kaminetsky JC. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. The Journal of Sexual Medicine. 2013;10(7):1842–1849 — PubMed PMID: 23634714 — 81 percent of 91 convenience-store samples drug-positive.
  4. Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Network Open. 2018;1(6):e183337 — PubMed PMID: 30646238 — 776 adulterated supplements, 2007–2016; sexual enhancement the largest category.
  5. Patel DN, Li L, Kee CL, et al. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. Journal of Pharmaceutical and Biomedical Analysis. 2014;87:176–190 — PubMed PMID: 23721687 — Why detecting designer analogues is so difficult.

The herb’s own safety record

  1. Wang J, Cao Y, Sun M, et al. Integrating metabolomics and bioinformatics to reveal the mechanism of Epimedium-induced liver injury. Biomedical Chromatography. 2024;38(9):e5948 — PubMed PMID: 38981997 — States that liver injury is the most common reported adverse effect; nominates icaritin as the hepatotoxic component.
  2. Tan K, Yang W, Pang L, Hou F. Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury. Medicine (Baltimore). 2022;101(32):e29909 — PubMed PMID: 35960048
  3. Qian HQ, et al. A systematic review of traditional uses, phytochemistry, pharmacology and toxicity of Epimedium koreanum Nakai. Journal of Ethnopharmacology. 2024;318(Pt B):116957. — PubMed PMID: 37544344
  4. Partin JF, Pushkin YR. Tachyarrhythmia and hypomania with horny goat weed. Psychosomatics. 2004;45(6):536–537 — PubMed PMID: 15546831 — The only published case report of a cardiac event attributed to this herb.
  5. Yong EL, Cheong WF, Huang Z, Thu WPP, Cazenave-Gassiot A, Seng KY, Logan S. Randomized, double-blind, placebo-controlled trial to examine the safety, pharmacokinetics and effects of Epimedium prenylflavonoids, on bone specific alkaline phosphatase and the osteoclast adaptor protein TRAF6 in post-menopausal women. Phytomedicine. 2021;91:153680 — PubMed PMID: 34352588 — The one monitored human safety dataset — clean, but only six weeks.
  6. Xu SF, et al. Effect of icariin on UDP-glucuronosyltransferases in mouse liver. Planta Medica. 2014;80(5):387–392 — PubMed PMID: 24710854 — In mice, liver UDP-glucuronosyltransferase activity was basically unaltered by icariin.
  7. Xiao HH, et al. Flavonoids from Herba epimedii selectively activate estrogen receptor alpha (ERα) and stimulate ER-dependent osteoblastic functions in UMR-106 cells. Journal of Steroid Biochemistry and Molecular Biology. 2014;143:141–151 — PubMed PMID: 24607839 — The basis of the hormone-sensitivity caution.
  8. Zhang G, Qin L, Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. Journal of Bone and Mineral Research. 2007;22(7):1072–1079 — PubMed PMID: 17419678 — Includes the reassuring 24-month endometrial-thickness and oestradiol findings.

Why the drug interaction matters to this population

  1. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005;294(23):2996–3002. — PubMed PMID: 16414947
  2. Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, Aznaouridis KA, Stefanadis CI. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circulation: Cardiovascular Quality and Outcomes. 2013;6(1):99–109. — PubMed PMID: 23300267

PubMed Topic Searches

  1. PubMed: Sildenafil adulteration of supplements
  2. PubMed: Designer PDE5 analogues in supplements
  3. PubMed: Epimedium and liver injury
  4. PubMed: Herb-induced liver injury
  5. PubMed: Nitrates and PDE5 inhibitors
  6. PubMed: Priapism and PDE5 inhibitors
  7. PubMed: Icariin and oestrogen receptors
  8. PubMed: Supplement-related emergency visits

Connections


Back to Table of Contents